Comorbidities in patients with alopecia areata
To the Editor: Alopecia areata (AA) is a common, polygenic, T-lymphocyte-mediated nonscarring hair loss. 1 It has been associated with atopic dermatitis, allergic rhinitis, lupus erythematosus, psoriasis, thyroid disease, rheumatoid arthritis, celiac disease, and type 1 diabetes mellitus. [1] [2] [3] This research letter represents a review of Cleveland Clinic Alopecia Registry to assess comorbidities present in patients given a diagnosis of AA. To identify these comorbidities, we performed a retrospective chart review.
We identified patients given a diagnosis of varying severity of AA (n ¼ 584) from the Cleveland Clinic Alopecia registry in the period from 2005 to 2014. A control group of age-matched patients given a diagnosis of seborrheic dermatitis without hair loss was randomly selected (n ¼ 172). Absence of hair loss in control group was assessed by hair loss specialists to ensure validity. Data were collected on gender, age, and conditions previously associated with AA, such as atopy, nutritional deficiencies, thyroid disease, and psychiatric disorders. The criteria for inclusion were diagnosis of AA by a Cleveland Clinic dermatologist and presence of a current comorbidities list in the patient's medical record. The presence of (Table I) . Conditions positively associated with AA were eczema, thyroid disorders, vitamin-D deficiency, and anemia. Conditions negatively associated with AA were diabetes mellitus and irritable bowel syndrome. Among the female population, patients with AA had elevated androgen levels and higher rates of ovarian cysts (Table II) .
Our study adds insight into the common comorbid conditions affecting AA. Similar to prior studies, Values are n (%) unless otherwise specified. AA, Alopecia areata; CI, confidence interval; OR, odds ratio; PCOS, polycystic ovary syndrome.
we found an increased prevalence of thyroid disease, eczema, and anemia and decreased prevalence of diabetes mellitus and irritable bowel syndrome. 2, 3 In addition, patients with AA were more likely to have a vitamin-D deficiency and elevated androgen levels, which has not been described to our knowledge. Further insight into these comorbidities could help physicians better understand and treat AA.
Strengths of our study are that our team consisted of a group of hair specialists. Furthermore, the centralized AA registry used was detailed and manually entered, ensuring that relevant data were obtained for all patients. The main limitation of this study is that the comorbidity profile of the control group may be different from the general population. 4 In addition, the study was conducted at a tertiary care center and as such, the patients may have a more severe comorbidity profile than usual, and might have received additional health care elsewhere. Alopecia areata (AA) is an autoimmune disease that may seriously impair quality of life (QoL) especially in the area of mental health. 3 As no dependable treatment is known, psychological support is considered important for these patients.
This prospective pilot study aimed to test whether a mindfulness-based stress reduction (MBSR) program 1 could improve QoL and reduce psychological distress in adults with AA. This is a group program that focuses on the cultivation of mindfulness through meditation practices (ie, sitting meditation, body scan, yoga) and the integration of this capacity into everyday life as a resource for coping with physical symptoms and difficult emotions. Participants attend weekly sessions for 2 months. Regular out-of-class practice is required.
Adults with moderate/severe AA attending our outpatient clinic were offered a MBSR program as an adjunct to their usual therapy. Eight patients accepted and were matched by sex and age with control patients who continued their usual therapy alone (Table I ). All patients underwent clinical evaluation and completed self-reported measurements of AA-related QoL, psychological symptom status, and perceived stress at baseline, after 2 months (corresponding to the end of the MBSR course for participants) and after 6 months. These measurements were performed by means of 3 validated questionnaires, namely: the AA-QoL, 4 the Brief Symptom Inventory, 1 and the Perceived Stress
